Cytokinetics, Inc. (CYTK)
62.19
-0.08
(-0.13%)
USD |
NASDAQ |
Mar 05, 16:00
61.75
-0.44
(-0.71%)
Pre-Market: 08:01
Cytokinetics Cash from Investing (TTM) : 16.67M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Bristol Myers Squibb Co. | -4.132B |
| Molina Healthcare, Inc. | 312.00M |
| Lifecore Biomedical, Inc. | -4.76M |
| Corcept Therapeutics, Inc. | 69.76M |
| Ionis Pharmaceuticals, Inc. | -277.78M |